Payer PolicyActive
CMM-207: Epidural Adhesiolysis
EVICORE-MSK_ADVANCED-2C84AFE5
EviCore by Evernorth
Effective: October 22, 2018
Updated: January 13, 2026
created · Dec 5, 2025
Policy Summary
Epidural adhesiolysis (catheter- or endoscopy-based) is considered experimental, investigational, or unproven and is not supported as a covered therapy for back pain, with related CPT codes (62263, 62264, 62280, 62281, 62282) listed accordingly. The guideline cites insufficient scientific evidence, specifies no particular documentation requirements, and notes final reimbursement or prior‑authorization decisions depend on the individual health plan and claims-processing rules.
Coverage Criteria Preview
Key requirements from the full policy
"None — The guideline states there is insufficient scientific evidence to support the use of epidural adhesiolysis (by catheter or endoscopically) as a treatment for back pain and it is considered e..."
Sign up to see full coverage criteria, indications, and limitations.